Barna Vasarhelyi

4 Nagyvárad Square
Budapest, BU 1089, Hungary

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 92 publications

What is (not) considered normal? - Contemporary challenges of establishing laboratory reference intervals

What is (not) considered normal? - Contemporary challenges of establishing laboratory reference intervals

Journal: Orvosi hetilap
Published: May 04, 2026

Albuminuria for detection of chronic kidney disease: biomarker and therapeutic target

Albuminuria for detection of chronic kidney disease: biomarker and therapeutic target

Journal: Orvosi hetilap
Published: April 24, 2026

Frequency of antibody formation during biological therapies in inflammatory bowel diseases

Frequency of antibody formation during biological therapies in inflammatory bowel diseases

Journal: Orvosi hetilap
Published: December 18, 2025

Some remarks on the methodology of determining serum creatinine levels, transaminase activity, and albumin levels

Some remarks on the methodology of determining serum creatinine levels, transaminase activity, and albumin levels

Journal: Orvosi hetilap
Published: December 15, 2025

Interaction of Clinical Factors Modestly Predict Anti-TNF-Alpha Antibody Formation in a Real-World Cohort of Inflammatory Bowel Disease Patients.

Interaction of Clinical Factors Modestly Predict Anti-TNF-Alpha Antibody Formation in a Real-World Cohort of Inflammatory Bowel Disease Patients.

Journal: Biomedicines
Published: September 25, 2025

The extensive erythrocyte-plasma partitioning of trametinib - implications for pharmacokinetic studies and therapeutic drug monitoring.

The extensive erythrocyte-plasma partitioning of trametinib - implications for pharmacokinetic studies and therapeutic drug monitoring.

Journal: Pharmacological reports : PR
Published: September 20, 2025

A Nonparametric Population Pharmacokinetic Model of Selumetinib in Pediatric Patients Diagnosed With Neurofibromatosis-I or Plexiform Neurofibromas.

A Nonparametric Population Pharmacokinetic Model of Selumetinib in Pediatric Patients Diagnosed With Neurofibromatosis-I or Plexiform Neurofibromas.

Journal: CPT: pharmacometrics & systems pharmacology
Published: August 19, 2025

From Data to Dose: Diversity in Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy.

From Data to Dose: Diversity in Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy.

Journal: Pharmaceutics
Published: August 11, 2025

Intravenous vancomycin therapy of adults guided by pharmacokinetic-pharmacodynamic targets

Intravenous vancomycin therapy of adults guided by pharmacokinetic-pharmacodynamic targets

Journal: Orvosi hetilap
Published: February 05, 2025

Assays for Monitoring Apixaban and Rivaroxaban in Emergency Settings, State-of-the-Art Routine Analysis, and Volumetric Absorptive Microsamples Deliver Discordant Results.

Assays for Monitoring Apixaban and Rivaroxaban in Emergency Settings, State-of-the-Art Routine Analysis, and Volumetric Absorptive Microsamples Deliver Discordant Results.

Journal: Diagnostics (Basel, Switzerland)
Published: July 07, 2024

Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy.

Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy.

Journal: Pharmaceutics
Published: May 27, 2024

Prevalence and determinants of diagnosed and undiagnosed diabetes in Hungary based on the nationally representative cross-sectional H-UNCOVER study.

Prevalence and determinants of diagnosed and undiagnosed diabetes in Hungary based on the nationally representative cross-sectional H-UNCOVER study.

Journal: Diabetes research and clinical practice
Published: May 15, 2024
Showing 1-12 of 92

Last Updated: 09/26/2026